Company page

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.